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Introduction: In 2013, the annual influenza immunisation programme in England was extended to chil-
dren to reduce the burden of influenza, but uptake was sub-optimal at 53.2%.
Aim: To explore the reasons some parents decided not to vaccinate their child against influenza as part of
the pilot programme offered in schools.
Methods: Cross-sectional qualitative study conducted between February and July 2015. 913 parents
whose children were not vaccinated against influenza in the school pilots in West Yorkshire and
Greater Manchester, England, were asked to comment on their reasons for non-vaccination and invited
to take part in a semi-structured interview. 138 parents returned response forms, of which 38 were eli-
gible and interested in participating and 25 were interviewed. Interview transcripts were coded by theme
in NVivo.
Results: A third of parents who returned response forms had either vaccinated their child elsewhere,
intended to have them vaccinated, or had not vaccinated them due to medical reasons (valid or per-
ceived). Most interviewees were not convinced of the need to vaccinate their child against influenza.
Parents expressed concerns about influenza vaccine effectiveness and vaccine side effects. Several par-
ents interviewed declined the vaccine for faith reasons due to the presence of porcine gelatine in the vac-
cine.
Conclusions: To significantly decrease the burden of influenza in England, influenza vaccination coverage
in children needs to be >60%. Hence, it is important to understand the reasons why parents are not vac-
cinating their children, and to tailor the communication and immunisation programme accordingly. Our
finding that a third of parents, who did not consent to their child being vaccinated as part of the school
programme, had actually vaccinated their child elsewhere, intended to have their child vaccinated, or had
not vaccinated them due to medical reasons, illustrates the importance of including additional questions
or data sources when investigating under-vaccination.
 2017 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Influenza causes considerable morbidity and mortality world-
wide and represents a public health problem with significant
socio-economic implications [1]. A core strategy for controlling
influenza is annual seasonal influenza vaccination, recommended
in high risk groups (individuals with specific chronic medical con-
ditions, pregnant women, children, adults over 65 years old, and
health care workers) [1]. The groups targeted in national influenza
immunisation programmes vary by country [1,2] and vaccination
coverage rates differ according to target group, country and region
[1,3]. There have been numerous studies exploring reasons for
non-vaccination with influenza vaccine globally, with the majority
focused on healthcare workers [4].
The Strategic Advisory Group of Experts (SAGE) on Immunisa-
tion’s vaccine hesitancy working group has defined vaccine hesi-
tancy as: ‘‘a behaviour, influenced by a number of factors
including issues of confidence (do not trust vaccine or provider),
complacency (do not perceive a need for a vaccine, do not value
the vaccine), and convenience (access)” [5]. Vaccine hesitancy is
complex and context specific, varying across time, place and vacci-
http://dx.doi.org/10.1016/j.vaccine.2017.08.016
0264-410X/ 2017 The Author(s). Published by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Abbreviations: LAIV, live attenuated influenza vaccine; NHS, National Health
Service; PHE, Public Health England.
⇑ Corresponding author.
E-mail addresses: pauline.paterson@lshtm.ac.uk (P. Paterson), tracey.chan-
tler@lshtm.ac.uk (T. Chantler), heidi.larson@lshtm.ac.uk (H.J. Larson).
Vaccine xxx (2017) xxx–xxx
Contents lists available at ScienceDirect
Vaccine
journal homepage: www.elsevier .com/locate /vacc ine
Please cite this article in press as: Paterson P et al. Reasons for non-vaccination: Parental vaccine hesitancy and the childhood influenza vaccination school
pilot programme in England. Vaccine (2017), http://dx.doi.org/10.1016/j.vaccine.2017.08.016
nes [5,6], and has the potential to pose a significant threat to global
efforts to reduce the burden of seasonal and pandemic influenza.
Hence, it is vital to understand the reasons people are hesitant
about receiving influenza vaccines across different contexts [5,7,8].
In 2012, the Joint Committee on Vaccination and Immunisation
(JCVI) recommended the extension of the influenza immunisation
programme to children, based on an analysis which highlighted
the cost effectiveness of vaccinating children due to direct and
indirect benefits to the individual and the population [8]. Due to
the scale of the programme (9 million children aged 2–17 years),
the programme is being implemented in phases [9]. The first phase
started in 2013/14, with 2–3 year olds offered the influenza vac-
cine through general practices (GPs) and a pilot of 4–11 year olds
in seven geographical areas across England, mostly offered through
children’s primary schools apart from one very rural area where
the vaccine was offered through local pharmacies and GPs [9]. In
2014/15, the national programme was expanded from 2 to 3 year
olds to include 4 year olds (provided through GPs as before). The
pilot of primary school aged children continued, and an additional
16 pilot areas introduced vaccination for secondary school stu-
dents in years 7 and 8. As vaccine uptake was low at 53.2% [10],
we conducted this qualitative study to explore the reasons some
parents decided not to vaccinate their child against influenza as
part of the school pilot programme, and how these could be
addressed.
2. Methods
2.1. Study population, recruitment and sampling
The study population consisted of parents, in West Yorkshire
and Greater Manchester, who chose not to vaccinate their child
against influenza in the school pilot programme in the 2014/15
season, but were willing to be contacted for further information.
We chose West Yorkshire and Greater Manchester as vaccine
uptake in the school influenza pilots had been had been low in
these areas and the regions were diverse demographically. The
pilot programme took place in 20 schools in West Yorkshire and
94 schools in Greater Manchester. The providers were community
based health organisations that administered and delivered immu-
nisations in schools.
Study invitation packs were distributed by the organisations
who were administering the pilot programmes in these areas. They
included a cover letter introducing the research topic, an informa-
tion sheet giving further details about the study, and a response
form (Appendix 1). The response form allowed respondents to reg-
ister their interest in participating in an interview, and also
included the question ‘‘We would be grateful if you could tell us
why you decided not to vaccinate your child as part of the school
immunisation programme”.
We applied a purposive sampling approach to ensure that our
sample reflected a wide range of socio-demographic characteristics
and supplemented this with snowball sampling, asking parent par-
ticipants if they knew anyone else who had refused vaccination
that might be interested in participating in the study.
Study data were collected through semi-structured interviews
using an interview topic guide (Appendix 2). The topic guide cap-
tured basic socio-demographic information and covered five main
subject areas: (1) Participants understanding and experience of the
childhood flu immunisation pilots, (2) decision-making about par-
ticipation in the flu pilots, (3) reasons for not accepting the flu vac-
cine, (4) risk–benefit considerations, and (5) where they
considered themselves on the spectrum of vaccine hesitancy. The
interview guide was developed to encourage participants to talk
and give their views and opinions, and not with the intention of
convincing parents to immunise their child. With the permission
of study participants, interviews were recorded verbatim with
the use of a digital recorder. Interview recordings were transcribed
anonymously by a professional transcription service.
In total, 1223 invitation packs were sent to 913 parents, in West
Yorkshire and Greater Manchester, who did not consent to their
child being vaccinated against influenza as part of the childhood
pilot programme but agreed to be contacted (January – February
2015). 138 parents returned response forms, of which fifty-nine
parents expressed interest in being interviewed as part of the
study, and 38 of the 59 were eligible (they did not want their child
to be vaccinated as part of the childhood flu pilot programme)
(Fig. 1). We approached all 38 eligible parents. Thirteen parents
were unavailable (either did not answer the phone or were unable
to meet) and one parent was no longer interested. One additional
parent was identified through snowballing and agreed to be
interviewed.
In total, we interviewed 25 parents. Twenty-two interviews
were audio-recorded face-to-face, two interviews were audio-
recorded over the phone, and one interview was carried out face-
to-face with note taking and no audio recording. Of the 25 parents
interviewed, 21 were mothers, four were fathers, 16 were from
West Yorkshire and nine from Greater Manchester. The parents
ranged in age from 33 to 49 years (mean 43 yrs, median 44 yrs).
Two parent’s children were in primary school and 23 were in sec-
ondary school. Thirteen interviewees were ‘White-British’, six
‘Asian British – Indian’ and three ‘Asian British – Pakistani’. Eleven
parents interviewed were Muslim (adherent of Islam), nine were
Christian, and five stated they had no religion.
2.2. Data analysis
Interview transcripts were coded with a thematic analysis tech-
nique [11] using the qualitative analysis software QSR Interna-
tional’s NVivo 11. Two investigators (PP & TC) coded the
transcripts, when developing the coding framework, to develop
an initial codebook with consensus around the key themes of the
analysis.
600 packs sent 
Greater Manchester West Yorkshire 
196 packs sent and then 193 
packs resent (3 had 
responded) in North Kirklees 
Parents
who did not consent to their child being vaccinated with inﬂuenza as 
part of the school pilot programme but agreed to be contacted 
117 packs sent and then 
117 packs resent in South 
Kirklees 
We received 
138 outreach forms 
In total 1223 invitaon packs 
were sent to 913 parents 
59 parents expressed 
interest in being interviewed 
38 eligible 
25 parent interviews 
13 unavailable 
1 no longer interested 
1 addional via 
snowballing 
21 not eligible 
Fig. 1. Flow chart of study participants.
2 P. Paterson et al. / Vaccine xxx (2017) xxx–xxx
Please cite this article in press as: Paterson P et al. Reasons for non-vaccination: Parental vaccine hesitancy and the childhood influenza vaccination school
pilot programme in England. Vaccine (2017), http://dx.doi.org/10.1016/j.vaccine.2017.08.016
2.3. Ethics
This study was reviewed and approved by the LSHTM Observa-
tional Research Ethics Committee (LSHTM Ethics ref 8710). The
study investigators obtained informed consent from participants
before each interview. Anonymity of participants has been main-
tained when presenting the study findings.
3. Results
3.1. Response forms
We received 138 response forms (15.1%). In response to the
question on the form ‘‘We would be grateful if you could tell us
why you decided not to vaccinate your child as part of the school
immunisation programme”, 47 parents and guardians (34%) indi-
cated that either their child was already vaccinated (n = 13), they
wanted to vaccinate their child (n = 6), or they could not vaccinate
their child due to medical reasons (n = 28); 83 parents and guar-
dians (60%) responded that their child was not vaccinated due to
a lack of perceived need for the vaccine or due to safety and other
concerns discussed below; and eight parents and guardians (6%)
did not give a reason (Fig. 2).
The most frequently cited concerns were about the presence of
porcine gelatine (40), side effects (13), and effectiveness of the vac-
cine (12) (NB. parents could list more than one concern). Other
concerns included the presence of chemicals in the vaccine, con-
cerns about the vaccination programme being a pilot or about it
being a new vaccine, concerns over the perception that their chil-
dren were being used to protect others, suspicions about business
motives, mistrust of the health service, concerns about vaccine
delivery, concerns about testing drugs on children, and concerns
about there being too many vaccines.
3.2. Interview findings
3.2.1. No perceived need for the vaccine
Twenty-two parents interviewed expressed the view that their
child did not need the influenza vaccine. These parents viewed
their child as healthy, with a strong immune system, or at low risk
of catching influenza, thought that it was better to build their
immune system with disease, or thought that if their child were
to get influenza that their child would be at low risk of complica-
tions: ‘‘He is healthy; he’s very active; he’s not ill very often. . . I
could understand the reason why you’d have it done if he was in
any way unwell, or had any health issues” (P4); ‘‘How do we build
up his own immune system against things, and how do we fight
things if we’re always vaccinating?” (P9).
3.2.2. Concerns about vaccine effectiveness and safety
Eleven of the parents who were interviewed voiced concerns
about the effectiveness of the vaccine: ‘‘The people I’m aware of
who have had vaccinations have then developed flu, and in one
case, quite a serious case of it. So, I’m not entirely convinced of
its effectiveness” (P7); ‘‘Several children at my daughter’s school,
after four weeks of having the vaccination were off school with
flu. My [unvaccinated] daughter’s not been off school with flu yet”
(P14).
Ten parents were concerned about side effects from the vaccine.
One parent’s older daughter had a high fever and vomiting follow-
ing vaccination a previous year. Since then, the mother has not had
either of her daughters vaccinated against influenza due to con-
cerns about side effects. This parent also had concerns about the
influenza vaccine being a nasal spray: ‘‘I read about. . . the spray
one [vaccine] being a little tad more dangerous because it’s so near
to the brain” (P15). Another parent was influenced by her mother
that was concerned about side effects: ‘‘My mum always tells
me, ‘I hate the flu vaccine because it makes me poorly afterwards.’
I think my kids are fine, I’m going to give them the vaccine and
they’re going to get poorly” (P23).
3.2.3. Concerns about vaccine constituents: porcine
Eleven parents interviewed declined the vaccine for religious
reasons due to the presence of porcine gelatine in the vaccine:
‘‘In Islam we’re forbidden to have any, we’re forbidden to eat pig
meat and have anything derived from pig” (P2); ‘‘It had gelatine,
and we know that we don’t consume gelatine because it’s derived
from a pig, so I just put no” (P6). Two parents specifically stated
that although there may have been transformation of the porcine
during the vaccine production process it was still not permissible
to eat, inject or inhale it: ‘‘No matter how much it changes, the
source remains the same” (P3).
For the parents that declined the vaccine for faith reasons, reli-
gion also influenced other health decisions, and they actively iden-
tify porcine content in other products, and seek alternative
products or ways to remove the porcine component, such as emp-
tying contents of medication from gelatine capsules: ‘‘Our GPs
know. . . they will offer it [an alternative medicine without porcine
Child not 
vaccinated due to 
concerns or a lack 
of perceived need 
for the vaccine, 
83, 60% 
Child either 
vaccinated or 
wanted their child 
to be vaccinated, 
or could not for 
medical reasons, 
47, 34% 
No reason given, 
8, 6% 
Fig. 2. Reasons given by parents and guardians, on the outreach form, for not vaccinating their child.
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gelatine] to us. . . The pharmacist will say you can open your cap-
sule. . . and use the powder” (P6).
Most of the parents who did not vaccinate their child for faith
reasons due to the presence of porcine, stated they would vacci-
nate their child if there was the option of an alternative vaccine
that did not contain porcine: ‘‘If you can’t have it due to your reli-
gion, there should be an alternative, I think, even if it’s not as effec-
tive” (P6).
3.2.4. Factors that would help address vaccine hesitancy
Parents stated that they would be more likely to accept influ-
enza immunisation for their child in the future if there was an epi-
demic among children, or if family or friends became at risk, and if
they were given more information: ‘‘If you said to me that he was
at high risk and it was life-threatening then I would do it” (P13).
Several participants requested receiving information about how
the school flu pilots went: ‘‘I’d like to know what went on in the
pilot scheme, how effective it was. . . if they said, well, normally
60% of children get flu and this year it’s only 10%, I might look at
it and think well actually maybe I should change my mind”
(P12); ‘‘Has the vaccination really made a difference because that
will influence my next year’s decision on whether anything is
worth having” (P10). For parents who did not vaccinate their child
for faith reasons, there was some positivity but also some uncer-
tainty as to whether reassurance from religious leaders would
influence parent’s decision to vaccinate their child.
4. Discussion
This study aimed to examine parental concerns about the influ-
enza vaccine and explore how these concerns influenced their
decision not to vaccinate their child during the 2014/15 childhood
influenza immunisation pilots in West Yorkshire and Greater
Manchester.
The study highlighted a range of parental concerns and a lack of
perceived need for the influenza vaccine for children. Parents sta-
ted they would consider vaccinating their child in future years if
they received feedback as to how the childhood vaccination pro-
gramme had reduced the amount of influenza. Other parents
wished to be told why their child’s age group was being targeted.
A previous study has shown that one of the reasons for not being
immunised was also a lack of information [12]. However, it is
worth noting the difficulties and complexities of addressing vac-
cine hesitancy and of directly correcting misperceptions [13].
The main reasons given for the view that influenza vaccine was
not needed for their children was that parents felt that their child
was healthy, with a strong immune system, at low risk of catching
influenza, that it is better to build their immune system with dis-
ease, and the view that if their child were to get influenza that their
child would be at low risk of complications. These views have been
reported in past studies on vaccine hesitancy of influenza vaccine
and other childhood vaccines [4,5,14,15]. Reported concerns about
vaccine effectiveness and concerns about side effects have also
been identified in previous vaccine hesitancy studies [4,14–18].
Studies investigating the issue of non-vaccination due to reli-
gious beliefs about porcine-containing products, as identified in
our research, have been conducted, as well as efforts to find ways
to address hesitancy. In 2001, a group of Islamic scholars were con-
vened byWHO to discuss and find ways to address the issue of por-
cine in vaccines and medicinal products and a statement was
released confirming that: ‘‘The scholars determined that the trans-
formation of pork products into gelatin alters them sufficiently to
make it permissible for observant Muslims to receive vaccines con-
taining pork gelatin and to take medicine packaged in gelatin cap-
sules” [19]. Despite this statement, local concerns and hesitation
continued, such as in India and Pakistan, where concerns were
voiced about the oral polio vaccine containing porcine gelatine
[20]. A more recent global study exploring animal derived medici-
nal products and religious patients’ beliefs found that Muslims did
not accept the use of porcine derived drugs, dressings or implants,
unless in an emergency with no alternatives available [21].
Another study, examining the perceptions of Muslim patients
and the influence of Muslim faith on medicine concordance, found
that 58% of survey respondents would stop taking a medicine if
they found out that it was haram (forbidden) [22]. In our study
in England, global statements, such as the one issued by WHO,
reflecting the views of multiple Islamic scholars, did not change
the minds of some who deferred to their local religious leader over
global statements.
Study limitations include the possibility of sample bias, since
those that took part in our study might have different views to that
of the general population. Muslim parents were overrepresented.
Also, for example, parents who participated in our study might
be more vocal or have a stronger viewpoint than others who did
not return the consent form, agree to be contacted or illustrate
interest in participating in our study.
Although our findings are not generalizable and cannot be
extrapolated to be representative of all parents who did not accept
the influenza vaccine for their child in West Yorkshire and Greater
Manchester, this qualitative research increases awareness of differ-
ent perspectives and views and reasons for non-vaccination, and
has informed future delivery and communication strategies in Eng-
land. For example, the childhood influenza information leaflet was
adapted and now includes an additional section on children who
were vaccinated last year needing a vaccine this year (to raise
awareness that the vaccination is annual), and the word ‘pigs’ is
only referred to once in the new leaflet instead of twice (parent
feedback was that the word ‘pig’ could put people off).
5. Conclusions
The JCVI recommends a higher than 60% coverage of influenza
vaccine in children in order to significantly decrease the burden
of influenza in England. To achieve this target, it is important to
understand the reasons why parents are choosing not to vaccinate
their children, and to tailor the communication and immunisation
programme to address this vaccine hesitancy. Thirty-four percent
of parents, who did not consent to their child being vaccinated as
part of the school programme, had actually vaccinated their child
elsewhere, intended to have their child vaccinated, or had not vac-
cinated them due to medical reasons (whether valid or perceived).
This finding illustrates the importance of including additional
questions or data sources when investigating under-vaccination.
This study highlights the nature and range of parental concerns
about the influenza immunisation school pilot programme in West
Yorkshire and Greater Manchester, England, during the 2014/15
school pilots. The majority of parents interviewed illustrated a lack
of perceived need for the influenza vaccine for children. Other
issues expressed by parents about the vaccine were concerns about
the presence of porcine gelatine, concerns about the vaccine’s
effectiveness and concerns about vaccine side effects. This study
is a reminder of the importance of asking parents their reasons
for non-vaccination to identify all reasons, including perhaps unex-
pected ones.
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